- Copy to the firm. Since 1997, FDA has routinely given the inspected firm a copy of the EIR's narrative once the inspection is closed [2].
- Delayed when action is pending. Inspections that lead to agency action, such as a warning letter, aren't eligible for that release until closed [1].
On FDA Intel
Related terms
Form 483483 responseNAI/VAI/OAI
Sources
- FDA guidance document
- govinfo.gov/content/pkg/FR-1997-04-14/html/97-9529.htm